A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines

Summary

A single center, Open-Label phase IV clinical trial is to be conducted in healthy elders (equal to or more than 61 years to evaluate the immunogenicity and safety of Sinovac's 15μg H1N1 influenza A Vaccine (Split virion), Inactivated.

Timeline

Start

2009-09

Primary completion

2009-10

Completion

2009-11

Drugs

Indications